Interpharm Holdings, Inc.
IPAH · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | 6/30/2004 | |
|---|---|---|---|---|
| Revenue | $75,587 | $63,355 | $39,911 | $41,100 |
| % Growth | 19.3% | 58.7% | -2.9% | – |
| Cost of Goods Sold | $53,920 | $45,927 | $30,839 | $31,305 |
| Gross Profit | $21,667 | $17,428 | $9,072 | $9,795 |
| % Margin | 28.7% | 27.5% | 22.7% | 23.8% |
| R&D Expenses | $18,962 | $10,674 | $4,003 | $538 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $13,443 | $11,521 | $5,164 | $4,196 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$103 | $0 | $0 | $1 |
| Operating Expenses | $32,405 | $22,195 | $9,167 | $4,735 |
| Operating Income | -$10,738 | -$4,767 | -$95 | $5,060 |
| % Margin | -14.2% | -7.5% | -0.2% | 12.3% |
| Other Income/Exp. Net | -$3,130 | -$723 | -$127 | $49 |
| Pre-Tax Income | -$13,868 | -$5,490 | -$222 | $5,109 |
| Tax Expense | $190 | -$1,700 | -$73 | $1,986 |
| Net Income | -$14,058 | -$3,790 | -$149 | $3,123 |
| % Margin | -18.6% | -6% | -0.4% | 7.6% |
| EPS | -0.26 | -0.15 | -0.01 | 0.16 |
| % Growth | -73.3% | -1,400% | -106.3% | – |
| EPS Diluted | -0.26 | -0.15 | -0.01 | 0.04 |
| Weighted Avg Shares Out | 65,242 | 36,521 | 25,684 | 17,595 |
| Weighted Avg Shares Out Dil | 65,242 | 36,521 | 25,684 | 16,404 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,554 | $1,534 | $1,248 | $886 |
| EBITDA | -$8,184 | -$3,233 | $1,153 | $5,946 |
| % Margin | -10.8% | -5.1% | 2.9% | 14.5% |